Labcorp Holdings (LH) Receives a Buy from Evercore ISI
Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Labcorp Holdings today and set a price target of $280.00.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Anderson CFA is an analyst with an average return of -2.1% and a 48.60% success rate. Anderson CFA covers the Healthcare sector, focusing on stocks such as Align Tech, Henry Schein, and Humana.
In addition to Evercore ISI, Labcorp Holdings also received a Buy from Robert W. Baird’s Eric Coldwell in a report issued today. However, on the same day, TipRanks – PerPlexity downgraded Labcorp Holdings (NYSE: LH) to a Hold.
Based on Labcorp Holdings’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $3.56 billion and a net profit of $261.1 million. In comparison, last year the company earned a revenue of $3.28 billion and had a net profit of $169.3 million
Read More on LH:
Disclaimer & DisclosureReport an Issue
- Labcorp price target raised to $326 from $313 at Baird
- Labcorp price target raised to $330 from $319 at JPMorgan
- Labcorp: Short-Term Headwinds but Strengthening 2026 Outlook Supports Buy Rating
- Labcorp Earnings Call Highlights Growth, Investment, Risks
- Labcorp guidance ‘should be well received,’ says Morgan Stanley
